Research / Unapproved

Humanin Peptide: Research Status and Trial Overview

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC119H204N34O32S2
Molecular weight2687.2 g/mol
Registered trials7
PubChem CID16131438

Regulatory Status

Humanin is classified as unapproved and research-only. No regulatory label, approved indication, or approved brand exists for this peptide.

What Humanin Is

Humanin is a short peptide (molecular formula C119H204N34O32S2, molecular weight approximately 2,687 daltons) cataloged in PubChem under CID 16131438. It has no approved drug label, no approved mechanism of action statement, and no approved pharmacologic class designation on file.

Trial Footprint

Registries list 7 total trials referencing humanin. The available sample trials are not tests of humanin as a treatment. They are studies measuring humanin as a biological marker in other clinical contexts: one recruiting study examines muscle biopsies in cerebral palsy, another recruiting trial looks at high-intensity exercise in people with dialyzed or conservatively managed chronic kidney disease, and a third recruiting study compares anesthesia types and their effect on ferroptosis and humanin levels during renal transplantation. None of these trials report results yet, and none evaluate humanin for a therapeutic use.

FAQ

Is humanin an FDA-approved drug?
No. Humanin has no approved label, no approved brand name, and no approved indication. It is classified as an unapproved research compound.
What is humanin used for in current research?
Current registered trials use humanin as a biological marker rather than as a treatment being tested. For example, studies are measuring humanin levels in the context of kidney disease, renal transplantation anesthesia, and muscle biopsy research in cerebral palsy.
How many clinical trials mention humanin?
Registries show 7 total trials that reference humanin. The trials with available details are all still recruiting and none have reported results.
Does humanin have known side effects in humans?
No adverse event data for humanin is available in the reviewed sources. Because it lacks an approved label, there is no official safety or side effect profile to reference.
What kind of molecule is humanin?
Humanin is a peptide with the molecular formula C119H204N34O32S2 and a molecular weight of roughly 2,687 daltons. It is cataloged in PubChem under CID 16131438.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem ClinicalTrials.gov

Updated 2026-08-03